Skip to main content

Table 1 Results of system suitability

From: A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form

Parameters for system suitability

Result

Acceptance criteria

LAM

DOL

Retention time

2.169

6.367

For information

%RSD for area count of 6 standard replicate injections

0.7

0.8

NMT 2.0

Tailing factor

1.34

1.12

NMT 2.0

Theoretical plates

7643

55924

NLT 2000

Resolution

N/A

22.51

NLT 2.0